INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 1978

Supplemental ascorbate was linked to longer survival times in terminal cancer patients compared to matched controls.

Researchers analyzed survival times in 100 terminal cancer patients given supplemental ascorbate (usually 10 g/day) as part of routine management and 1,000 matched controls who received the same treatment except for ascorbate. Ascorbate-treated patients were found to have a mean survival time about 300 days greater than controls. Survival times exceeding 1 year after the date of untreatability were seen in 22% of ascorbate-treated patients compared to 0.4% of controls. Among these 22 patients, mean survival time was 2.4 years after reaching the terminal stage, and 8 were still alive with a mean survival time of 3.5 years.

Shows an association, not proof of cause and effect.

Study type
Matched cohort study
Who was studied
100 terminal cancer patients given supplemental ascorbate and 1,000 matched controls
What was measured
Survival times from the date of untreatability and from first hospital attendance

THE PAPER

Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

Cameron E, Pauling L. Proc Natl Acad Sci U S A, 1978.

PubMed 279931 ↗DOI 10.1073/pnas.75.9.4538 ↗

CancerNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.